You may also like
Comparison of Two Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery
Tranexamic acid (TA), a synthetic antifibrinolytic drug, has been shown to reduce postoperative bleeding and the need for allogeneic blood transfusion in cardiac surgery. However, the optimal dose regimen of TA is still under debate. The aim of this study was to evaluate whether a lower-dose TA regimen produced equivalent efficacy to its higher-dose counterpart in reducing postoperative bleeding and transfusion needs.
Poloidal-Toroidal Decomposition: Does Our Universe Have a Heartbeat or Vise Versa? (EP Video)
Dr. Michael Black discusses our universe and somehow manages to relate it all to heart surgery (39:37 minutes).
Cardiovascular Manifestations and Treatment Considerations In COVID-19
COVID-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest.